Product Program year 2024 Source: CMS Open Payments

Tracleer

Drug Cardiology

NDC 66215-102-06

Open in the dashboard

General payments

$8,378

8 payments

Research payments

$0

0 payments

Through program year 2024, $8,378 in general payments and $0 in research payments were reported against Tracleer (Cardiology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2024 General $1,929 3
2023 General $1,350 1
2021 General $2,500 1
2020 General $2,500 1
2019 General $99 2

Breakdown

Who paid General payments · program years 2019–2024
  1. Actelion Pharmaceuticals US, Inc. $5,099 4 payments
  2. Johnson & Johnson Health Care Systems Inc. $3,279 4 payments
Top recipients General payments · program year 2024
  1. Nafis Shamsid-Deen Internal Medicine · Phoenix, AZ $1,090 57% · 1 payment
  2. Brenda Pacheco Physician Assistant, Medical · Acoma, NM $489 25% · 1 payment
  3. Charles Gallegos Nurse Practitioner, Family · Albuquerque, NM $350 18% · 1 payment

Each share is of general payments naming this product in 2024.

Specialties paid General payments · program year 2024
  1. Internal Medicine $1,090 57% · 1 practitioner
  2. Physician Assistant, Medical Physician Assistant $489 25% · 1 practitioner
  3. Nurse Practitioner, Family Nurse Practitioner $350 18% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. Arizona $1,090 57% · 1 recipient
  2. New Mexico $839 43% · 2 recipients

Each share is of general payments naming this product in 2024 where a state was reported.

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

798

Prescriptions dispensed, refills included

Drug cost

$10,462,801

Paid at the pharmacy, in all

Prescribers

59

With 11 or more claims of it

Medicare Part D drugs matched to TRACLEER, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Tracleer Bosentan Same name 59 798 $10,462,801

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 59 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Christine Archer Chicko Nurse Practitioner PA 35 $416,633 None on record
Sudarshan Rajagopal Cardiology NC 25 $297,523 None on record
Vallerie McLaughlin Cardiology MI 25 $297,343 None on record
Scott Cohen Cardiology WI 24 $285,593 None on record
Jose Tallaj Advanced Heart Failure and Transplant Cardiology AL 22 $275,304 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 59 with Patron
8 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record